Highlights of the first international "immunotherapy in pediatric oncology: Progress and challenges" meeting

Christian M. Capitini, Laurence J N Cooper, R. Maarten Egeler, Rupert Handgretinger, Franco Locatelli, Paul M. Sondel, Crystal L. MacKall

Research output: Contribution to journalArticle

Abstract

The first annual conference on immunotherapy in pediatric oncology was held in Bethesda, MD, from September 9 to 10, 2008 to discuss the state-of-the-art of immunotherapeutic strategies currently being explored in pediatric oncology. Major topics included targeting cell surface receptors, understanding and improving T-cell-based therapies, augmenting innate immune strategies, and enhancing graft-versus-leukemia for pediatric malignancies. As can be seen in the summaries of the individual presentations, significant progress has been made in developing preclinical models of pediatric tumors and a variety of novel immunobiologic therapies are approaching, or already in, the clinic. Although there is much excitement about the potential utility of these agents, a great deal of challenges lie ahead in improving the efficacy of each of these modalities and getting them to patients in a timely fashion. The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies.

Original languageEnglish (US)
Pages (from-to)227-244
Number of pages18
JournalJournal of Pediatric Hematology/Oncology
Volume31
Issue number4
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Immunotherapy
Pediatrics
Cell Surface Receptors
Cell- and Tissue-Based Therapy
Neoplasms
Leukemia
T-Lymphocytes
Transplants
Therapeutics

Keywords

  • Cell surface receptors
  • Graft-versus-leukemia
  • Immunotherapy
  • Innate immunity
  • T cells

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology
  • Medicine(all)

Cite this

Capitini, C. M., Cooper, L. J. N., Maarten Egeler, R., Handgretinger, R., Locatelli, F., Sondel, P. M., & MacKall, C. L. (2009). Highlights of the first international "immunotherapy in pediatric oncology: Progress and challenges" meeting. Journal of Pediatric Hematology/Oncology, 31(4), 227-244. https://doi.org/10.1097/MPH.0b013e31819a5d8d

Highlights of the first international "immunotherapy in pediatric oncology : Progress and challenges" meeting. / Capitini, Christian M.; Cooper, Laurence J N; Maarten Egeler, R.; Handgretinger, Rupert; Locatelli, Franco; Sondel, Paul M.; MacKall, Crystal L.

In: Journal of Pediatric Hematology/Oncology, Vol. 31, No. 4, 04.2009, p. 227-244.

Research output: Contribution to journalArticle

Capitini, CM, Cooper, LJN, Maarten Egeler, R, Handgretinger, R, Locatelli, F, Sondel, PM & MacKall, CL 2009, 'Highlights of the first international "immunotherapy in pediatric oncology: Progress and challenges" meeting', Journal of Pediatric Hematology/Oncology, vol. 31, no. 4, pp. 227-244. https://doi.org/10.1097/MPH.0b013e31819a5d8d
Capitini, Christian M. ; Cooper, Laurence J N ; Maarten Egeler, R. ; Handgretinger, Rupert ; Locatelli, Franco ; Sondel, Paul M. ; MacKall, Crystal L. / Highlights of the first international "immunotherapy in pediatric oncology : Progress and challenges" meeting. In: Journal of Pediatric Hematology/Oncology. 2009 ; Vol. 31, No. 4. pp. 227-244.
@article{327244bbeceb47489036f5d855b7bf63,
title = "Highlights of the first international {"}immunotherapy in pediatric oncology: Progress and challenges{"} meeting",
abstract = "The first annual conference on immunotherapy in pediatric oncology was held in Bethesda, MD, from September 9 to 10, 2008 to discuss the state-of-the-art of immunotherapeutic strategies currently being explored in pediatric oncology. Major topics included targeting cell surface receptors, understanding and improving T-cell-based therapies, augmenting innate immune strategies, and enhancing graft-versus-leukemia for pediatric malignancies. As can be seen in the summaries of the individual presentations, significant progress has been made in developing preclinical models of pediatric tumors and a variety of novel immunobiologic therapies are approaching, or already in, the clinic. Although there is much excitement about the potential utility of these agents, a great deal of challenges lie ahead in improving the efficacy of each of these modalities and getting them to patients in a timely fashion. The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies.",
keywords = "Cell surface receptors, Graft-versus-leukemia, Immunotherapy, Innate immunity, T cells",
author = "Capitini, {Christian M.} and Cooper, {Laurence J N} and {Maarten Egeler}, R. and Rupert Handgretinger and Franco Locatelli and Sondel, {Paul M.} and MacKall, {Crystal L.}",
year = "2009",
month = "4",
doi = "10.1097/MPH.0b013e31819a5d8d",
language = "English (US)",
volume = "31",
pages = "227--244",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Highlights of the first international "immunotherapy in pediatric oncology

T2 - Progress and challenges" meeting

AU - Capitini, Christian M.

AU - Cooper, Laurence J N

AU - Maarten Egeler, R.

AU - Handgretinger, Rupert

AU - Locatelli, Franco

AU - Sondel, Paul M.

AU - MacKall, Crystal L.

PY - 2009/4

Y1 - 2009/4

N2 - The first annual conference on immunotherapy in pediatric oncology was held in Bethesda, MD, from September 9 to 10, 2008 to discuss the state-of-the-art of immunotherapeutic strategies currently being explored in pediatric oncology. Major topics included targeting cell surface receptors, understanding and improving T-cell-based therapies, augmenting innate immune strategies, and enhancing graft-versus-leukemia for pediatric malignancies. As can be seen in the summaries of the individual presentations, significant progress has been made in developing preclinical models of pediatric tumors and a variety of novel immunobiologic therapies are approaching, or already in, the clinic. Although there is much excitement about the potential utility of these agents, a great deal of challenges lie ahead in improving the efficacy of each of these modalities and getting them to patients in a timely fashion. The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies.

AB - The first annual conference on immunotherapy in pediatric oncology was held in Bethesda, MD, from September 9 to 10, 2008 to discuss the state-of-the-art of immunotherapeutic strategies currently being explored in pediatric oncology. Major topics included targeting cell surface receptors, understanding and improving T-cell-based therapies, augmenting innate immune strategies, and enhancing graft-versus-leukemia for pediatric malignancies. As can be seen in the summaries of the individual presentations, significant progress has been made in developing preclinical models of pediatric tumors and a variety of novel immunobiologic therapies are approaching, or already in, the clinic. Although there is much excitement about the potential utility of these agents, a great deal of challenges lie ahead in improving the efficacy of each of these modalities and getting them to patients in a timely fashion. The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies.

KW - Cell surface receptors

KW - Graft-versus-leukemia

KW - Immunotherapy

KW - Innate immunity

KW - T cells

UR - http://www.scopus.com/inward/record.url?scp=65349125007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349125007&partnerID=8YFLogxK

U2 - 10.1097/MPH.0b013e31819a5d8d

DO - 10.1097/MPH.0b013e31819a5d8d

M3 - Article

C2 - 19346873

AN - SCOPUS:65349125007

VL - 31

SP - 227

EP - 244

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 4

ER -